(Q84591315)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20656109%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

PARP inhibition in BRCA-mutated breast and ovarian cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20656109%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20656109%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Tony Mok

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20656109%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

English

0 references

publication date

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20656109%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20656109%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20656109%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

9737

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20656109%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

211-213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20656109%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Breast cancer susceptibility genes. BRCA1 and BRCA2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Phase III Trial Comparing Three Doses of Docetaxel for Second-Line Treatment of Advanced Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Resistance to therapy caused by intragenic deletion in BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Hallmarks of 'BRCAness' in sporadic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961119-1

7 January 2021

10.1016/S0140-6736(10)61119-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20656109%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference